--- title: Ventas (VTR) — intrinsic value and fair price canonical: https://sweetvaluelab.com/stocks/vtr ticker: VTR as_of: 2026-10-17 sector: Real Estate industry: REIT - Healthcare Facilities --- # Ventas (VTR) Ventas (VTR) closed at $85.86 on Oct 16, 2026, overvalued by 24% vs its model value of $69.06 (from its own five-year median price to Cash FFO). ## Key figures | Figure | Value | | --- | ---: | | Last close | $85.86 (Oct 16, 2026) | | Model value (from its own five-year median price to Cash FFO) | $69.06 | | Price vs model | overvalued by 24% vs model | | Range of that model | $57.85 – $78.98 | | Market value | $44.0B | | P/E (fiscal 2025) | 159.0 | | Net margin (fiscal 2025) | 4.3% | | Free cash flow (fiscal 2025) | -$1.3B | | Dividend yield (trailing twelve months) | 2.38% | | Beta | 0.74 | | Cost of capital (WACC) | 7.49% | | Business classification | Mature & Stable (Moderate growth (~14% recent), Thin margins (4.5% net margin), Pays dividends, Highly cyclical earnings, Negative free cash flow) | ## Dividends | Figure | Value | | --- | ---: | | Trailing dividend yield | 2.38% | | Dividends per share, last 12 months | $2.04 | | Dividends / FFO (fiscal 2025) | 52.4% | | Raised | 1 years in a row | | Growth over 5 years | 2.5% a year | | Latest payment | $0.52, ex-date Sep 30, 2026, paid Oct 15, 2026 | | Year of payments | Dividends per share | | --- | ---: | | To Sep 30, 2021 | $1.80 | | To Sep 30, 2022 | $1.80 | | To Sep 29, 2023 | $1.80 | | To Oct 1, 2024 | $1.80 | | To Sep 30, 2025 | $1.89 | | Trailing twelve months (to Sep 30, 2026) | $2.04 | ## Valuation models Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026. | Model | Role | Value per share | Low | High | | --- | --- | ---: | ---: | ---: | | P/Cash FFO · own history | primary | $69.06 | $57.85 | $78.98 | | P/E · peers | cross check | $19.25 | $18.63 | $43.79 | | P/E · own history | cross check | $0.00 | $0.00 | $0.00 | | PEG | sanity check | $14.74 | $14.74 | $14.74 | | EV/EBITDA · peers | cross check | $21.83 | $13.77 | $34.68 | | EV/Revenue · peers | cross check | $78.71 | $51.63 | $127.26 | | Dividend discount | cross check | $59.44 | $39.70 | $94.78 | ## Insider activity (SEC Form 4) No open-market insider buys or sales filed in the past 90 days. | Date | Insider | Relationship | Transaction | Shares | Value | | --- | --- | --- | --- | ---: | ---: | | Oct 15, 2026 | Smith Maurice S | Director | Grant / award | 66.105 | $5,609.7 | | Oct 15, 2026 | Smith Maurice S | Director | Grant / award | 80.645 | $6,843.5 | | Oct 13, 2026 | Smith Maurice S | Director | Grant / award | 17.889 | $1,500 | | Oct 15, 2026 | Roy Sumit | Director | Grant / award | 55.161 | $4,681 | | Oct 15, 2026 | Roy Sumit | Director | Grant / award | 80.645 | $6,843.5 | ## Recent SEC filings | Filed | Form | What | Filing | | --- | --- | --- | --- | | Sep 15, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers | https://www.sec.gov/Archives/edgar/data/740260/000110465926107921/tm2625430d1_8k.htm | | Jul 30, 2026 | 10-Q | Quarterly report | https://www.sec.gov/Archives/edgar/data/740260/000074026026000024/vtr-20260630.htm | | Jul 29, 2026 | 8-K | 2.02 Results of Operations (Earnings); 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/740260/000074026026000022/vtr-20260729.htm | | Jun 15, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers; 8.01 Other Events | https://www.sec.gov/Archives/edgar/data/740260/000110465926074016/tm2617921d1_8k.htm | | May 15, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers; 5.07 Submission of Matters to a Shareholder Vote; 8.01 Other Events; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/740260/000110465926062795/tm2614646d2_8k.htm | ## Superinvestors holding it (latest 13F) | Manager | Quarter | Shares | Value | | --- | --- | ---: | ---: | | Christopher Davis | 2026-06-30 | 111,420 | $9.9M | 1 tracked managers in all. ## About Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland. --- Source: https://sweetvaluelab.com/stocks/vtr (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.